Canopy Growth Corp vs Salesforce Inc — how do they compare? Canopy Growth Corp trades at $0.96 (market cap $398.46M), while Salesforce Inc trades at $169.62 (market cap $137.23B). The key difference: Salesforce Inc is far larger — about 344.4× Canopy Growth Corp's market cap, and Salesforce Inc pays a 1.05% dividend while Canopy Growth Corp pays none. Which is the better fit depends on your goals.
| CGC | CRM | |
|---|---|---|
Market Cap | $398.46M | $137.23B |
Sector | Health | Technology |
52-Week High | $1.92 | $270.25 |
52-Week Low | $0.86 | $150.12 |
Enterprise Value | $337.90M | $167.28B |
Dividend Yield | — | 1.05% |
Signals from Pluang's Aura AI — not financial advice
Canopy Growth (CGC) trades at $0.96, down 1.15% on the day, with a mixed technical picture showing a bullish overall signal but bearish moving averages. The company reported a net loss of $598.12 million in 2025, with revenue declining to $269 million, though recent quarterly earnings showed one beat and two misses against expectations. Cash flow remains negative, but the balance sheet shows improving debt-to-asset ratios, down to 33.13% in 2025 from 53.61% in 2023.
The outlook is cautious; while cost-cutting and restructuring efforts are underway, profitability remains elusive, and the stock faces risks including potential delisting due to low share price. Analyst sentiment is divided, with 33% recommending buy, 41% hold, and 26% sell. Investors should weigh the potential for a turnaround against significant operational and regulatory challenges in the cannabis sector.
Salesforce (CRM) trades at $171.22, up 4.84% over 24 hours, with a bullish technical signal despite mixed momentum indicators. The company demonstrates strong fundamentals, including a 77.64% gross margin and consistent earnings beats, with Q1 2026 EPS of $3.88 exceeding the $3.13 estimate. Revenue grew to $37.90B in 2025, and operating cash flow reached $13.09B. Recent news highlights AI-driven growth potential, though the stock faces sector-wide volatility.
Outlook remains positive with a consensus price target of $235.90, implying 38% upside, supported by 73 buy ratings. Risks include competitive pressures in SaaS and macroeconomic sensitivity. AI adoption and strong cash flow generation present key opportunities for long-term investors.
Trailing returns across standard periods
Latest headlines on both assets
Canopy Growth, headquartered in Smiths Falls, Canada, cultivates and sells medicinal and recreational cannabis, and hemp, through a portfolio of brands that include Tweed, Spectrum Therapeutics, and CraftGrow. Although it primarily operates in Canada, Canopy has distribution and production licenses in more than a dozen countries to drive expansion in global medical cannabis and also holds an option to acquire Acreage Holdings upon U.S. federal cannabis legalization.
Read more on CGC →Salesforce Inc provides enterprise cloud computing solutions. The company offers customer relationship management technology that brings companies and customers together. Its Customer 360 platform helps the group to deliver a single source of truth, connecting customer data across systems, apps, and devices to help companies sell, service, market, and conduct commerce. It also offers Service Cloud for customer support, Marketing Cloud for digital marketing campaigns, Commerce Cloud as an e-commerce engine, the Salesforce Platform, which allows enterprises to build applications, and other solutions, such as MuleSoft for data integration.
Read more on CRM →